success lentivir vector cure fatal gene acquire disease open new era human gene therapy howe variable efficacy safety therapeutic approach report patient consent lentiviralvectorbas limit incur little understand under caps adverse effect poor ass role host variant character lentiviralvector within set collar cross mouse strain carry firefox luciferas cdn control liverspecif promote admins female mouse totalbodi heat express period monitor week postvector administer vector copy number per diploma genome liver spleen determine end studi identify major strainspecif contribute overall transduct biodistribut maximum kinen throughout result highlight import genetherapeut provide model rigor approach suggest redesign prelim studi genetherapi methodology might appropri 